Dashboard
Manage Tickers

GSKGSK plc

NYSE gsk.com


$ 44.68 $ 0.53 (1.2 %)    

Thursday, 09-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 44.67
$ 44.33
$ 0.00 x 0
$ 0.00 x 0
$ 44.33 - $ 44.72
$ 32.35 - $ 44.72
4,924,643
na
96.31B
$ 0.53
$ 15.34
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2
Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

pfizer-agrees-to-settle-over-10000-lawsuits-about-cancer-risks-associated-with-discontinued-heartburn-drug-zantac
Pfizer Agrees To Settle Over 10,000 Lawsui...
05/08/2024 18:58:30

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+...

bioversys-and-gsk-boost-fight-against-tuberculosis-with-expanded-partnership-and-series-c-funding-increase-by-chf-123m
BioVersys And GSK Boost Fight Against Tube...
05/07/2024 06:18:35

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis ...

gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook
GSK Sees Strong Demand For Vaccines and As...
05/01/2024 13:42:17

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...

wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-relief-why-this-analyst-sees-incoming-summer-rally
Wall Street Set To Open Lower After AMD Ea...
05/01/2024 10:44:10

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc...

gsk-expects-2024-core-eps-to-increase-between-8-to-10-versus-prior-guidance-of-increase-between-6-to-9
GSK Expects 2024 Core EPS To Increase Betw...
05/01/2024 09:34:22

gsk-expects-2024-core-operating-profit-to-increase-between-9-to-11-versus-prior-guidance-of-increase-between-7-to-10
GSK Expects 2024 Core Operating Profit To ...
05/01/2024 09:33:57

gsk-expects-2024-sales-to-increase-towards-the-upper-part-of-the-range-of-between-5-to-7-versus-previous-guidance-of-increase-of-5-7
GSK Expects 2024 Sales To Increase Towards...
05/01/2024 09:32:34

gsk-q1-adj-eps-109-beats-091-estimate-sales-933b-beat-892b-estimate
GSK Q1 Adj. EPS $1.09 Beats $0.91 Estimate...
05/01/2024 07:52:06

GSK (NYSE:GSK) reported quarterly adjusted earnings of $1.09 per share which beat the analyst consensus estimate of $0.91 by 20...

will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week
Will Earnings Cheer Continue To Buoy Marke...
04/29/2024 05:51:21

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

whats-going-on-with-pfizer-stock-on-thursday
What's Going On With Pfizer Stock On Thurs...
04/25/2024 17:51:32

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

Core News & Articles
CureVac Has Started The Phase 1 Part Of A ...
04/24/2024 11:20:32

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

Core News & Articles
CureVac And GSK Will End The Pandemic Prep...
04/24/2024 11:18:42

the-fda-has-accepted-supplemental-biologics-license-application-for-gsks-jemperli-dostarlimab-in-combination-with-standard-of-care-chemotherapy-to-expand-treatment-to-all-adult-patients-with-primary-advanced-or-recurrent-endometrial-cancer
The FDA Has Accepted Supplemental Biologic...
04/24/2024 10:58:04

Core News & Articles
As Part Of Wave Life Sciences' Ongoing Col...
04/23/2024 14:22:56

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next pha...

Core News & Articles
Sanofi To Pay $100M To Settle Zantac Cance...
04/22/2024 14:31:27

- Bloomberg

brexit-impact-on-drugs---rising-shortages-in-uk-highlight-brexit-challenges
Brexit Impact On Drugs - Rising Shortages ...
04/19/2024 15:39:26

Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages ...

once-valued-at-billions-23andmes-ceo-considers-privatization-to-secure-companys-future
Once Valued At Billions, 23andMe's CEO Con...
04/18/2024 16:06:23

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a fo...

gsk-says-its-blockbuster-shingles-vaccine-shows-high-efficacy-even-after-10-years
GSK Says Its Blockbuster Shingles Vaccine ...
04/17/2024 12:06:07

Lasting protection against shingles for adults over 50 with GSK's RZV vaccine. New data from ZOSTER-049 trial reveals over ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION